John H. Powers III Named Director of NIH Allergy Institute

HIN

National Institutes of Health (NIH) Director Jay Bhattacharya, M.D., Ph.D., today announced the selection of John H. Powers III, M.D., as director of NIH's National Institute of Allergy and Infectious Diseases (NIAID). Dr. Powers currently serves as NIAID Acting Director and Principal Deputy Director and as an infectious diseases attending physician for the institute in the NIH Clinical Center. NIAID conducts and supports basic and applied research to better understand, treat and ultimately prevent infectious, immunologic and allergic diseases.

"Dr. Powers is a physician-scientist who has spent more than three decades caring for patients, teaching and mentoring the next generation of investigators, and playing an integral role in research that improves lives. He has been a trusted and valued colleague within NIAID for several decades, and will bring a focus on rigor, transparency, and research outcomes to leading the institute into the future.," said Dr. Bhattacharya. "I am thankful for his commitment to serve and glad to permanently welcome him to the NIH leadership team."

As director, Dr. Powers will oversee the implementation of NIAID's research agenda, recently released through a new strategic plan, and shepherd the institute's annual budget of $6.56 billion. NIAID supports research to advance the understanding, diagnosis and treatment of infectious, immunologic, and allergic diseases. The institute also supports research at universities, scientific institutions, and small businesses around the United States, throughout the globe, and across NIAID's laboratories, including the Vaccine Research Center on NIH's main campus in Bethesda, Maryland, and the Rocky Mountain Laboratories in Hamilton, Montana. NIAID also has a unique role in supporting research that enables responses to emerging and re-emerging public health threats at home and abroad to improve the lives of Americans.

Dr. Powers brings more than three decades of experience spanning clinical medicine, infectious diseases research, regulatory science, clinical trial methodology and outcomes research. He has authored more than 150 peer-reviewed publications. His work has focused on improving how clinical trials are designed, conducted and interpreted so that studies measure outcomes that matter to patients, including survival, function, symptoms and quality of life. He has helped develop patient-reported outcome tools for influenza and chronic obstructive pulmonary disease, among other conditions, and has contributed to international standards for clinical outcome assessments and surrogate endpoints.

Dr. Powers has served at NIAID since 1999 as an infectious diseases attending physician and for the past two decades as Director of Collaborative Research at Leidos Biomedical Research, first in the Division of Clinical Research and most recently in support of the NIAID Office of the Director. He received NIH Director's Awards for his work responding to H1N1 influenza and the COVID-19 pandemic.

Before joining NIH, Dr. Powers served at the U.S. Food and Drug Administration (FDA) from 1998 to 2006 as a medical officer and later lead medical officer for antimicrobial drug development and resistance initiatives in the Office of Antimicrobial Products. He co-chaired the U.S. Federal Interagency Task Force on Antimicrobial Resistance and served on working groups with the Centers for Disease Control and Prevention, the Department of Veterans Affairs and the Foundation for the NIH. He is a recipient of the Medal of Honor from the US Veteran's Affairs and Public Health Service for clinical trials evaluation and outcomes research. He has testified before the U.S. House of Representatives Committee on Energy and Commerce on antibiotic resistance and drug development.

Dr. Powers is a professor of clinical medicine at the George Washington University School of Medicine and an affiliate professor at the University of Maryland School of Pharmacy. He has taught and mentored medical students, residents and fellows for more than 30 years, and he is a research editor at The BMJ. He received the FDA Award for Excellence in Mentoring and the Norman P. Salzman Mentoring Award.

Dr. Powers earned his bachelor's degree from the University of Pennsylvania, Philadelphia, and his medical degree from Temple University School of Medicine, also in Philadelphia. He completed his residency in internal medicine at Temple University Hospital, where he served as chief resident, and a fellowship in infectious diseases at the University of Virginia, Charlottesville.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.